Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Short term Debt (2016 - 2017)

Historic Short term Debt for Lisata Therapeutics (LSTA) over the last 8 years, with Q2 2017 value amounting to $450315.0.

  • Lisata Therapeutics' Short term Debt fell 9100.78% to $450315.0 in Q2 2017 from the same period last year, while for Jun 2017 it was $450315.0, marking a year-over-year decrease of 9100.78%. This contributed to the annual value of $3.1 million for FY2016, which is 2505.12% down from last year.
  • According to the latest figures from Q2 2017, Lisata Therapeutics' Short term Debt is $450315.0, which was down 9100.78% from $3.2 million recorded in Q1 2017.
  • Lisata Therapeutics' Short term Debt's 5-year high stood at $5.0 million during Q2 2016, with a 5-year trough of $213112.0 in Q4 2013.
  • Moreover, its 5-year median value for Short term Debt was $2.3 million (2016), whereas its average is $2.2 million.
  • Per our database at Business Quant, Lisata Therapeutics' Short term Debt plummeted by 9380.21% in 2013 and then soared by 93838.85% in 2015.
  • Over the past 5 years, Lisata Therapeutics' Short term Debt (Quarter) stood at $213112.0 in 2013, then soared by 420.67% to $1.1 million in 2014, then soared by 275.94% to $4.2 million in 2015, then decreased by 25.05% to $3.1 million in 2016, then tumbled by 85.6% to $450315.0 in 2017.
  • Its Short term Debt stands at $450315.0 for Q2 2017, versus $3.2 million for Q1 2017 and $3.1 million for Q4 2016.